parapneumonic syndrome.pptx

Upload: saga-sabara

Post on 03-Apr-2018

230 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    1/29

    PARAPNEUMONIC

    SYNDROME(Laporan Kasus)

    Arismunandar H.P.U

    0818011008

    1

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    2/29

    1. ANAMNESIS

    Identitas PasienNama : Tn. S

    Umur : 60 tahun

    Jenis Kelamin : Laki-laki Pekerjaan : Petani

    Agama : Islam

    Alamat : Punggur Tanggal Masuk : 19 Januari 2013,

    pukul 18.00 WIB

    2

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    3/29

    Keluhan Utama

    Buang air besar cair sejak 1 hari SMRS

    Keluhan Tambahan

    Demam,batuk berdahak, pilek, sesak

    3

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    4/29

    Riwayat Penyakit Sekarang Pasien datang ke IGD RSAY Metro dengan

    keluhan buang air besar cair sejak 1 hariSMRS. Buang air besar sebanyak 5 kali

    dengan konsistensi cair, ampas yang sedikitdan berlendir tanpa disertai darah. Pasien

    juga mengeluh demam yang naik turun dandisertai dengan pilek, batuk berdahak dan

    sesak serta dada terasa berat sejak 2 hariSMRS. Pasien juga mengaku tidak nafsumakan dan badan terasa lemas. Karenakhawatir akan kondisi dirinya, maka pasiendatang ke IGD RSAY Metro untuk berobat.

    4

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    5/29

    Riwayat Penyakit Dahulu

    Riwayat DM : disangkal

    Riwayat hipertensi :

    disangkal

    Riwayat sakit jantung : disangkal

    Riwayat minum OAT : disangkal

    Pasien belum pernah mengalami sakit

    seperti ini sebelumnya

    5

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    6/29

    Riwayat Penyakit Keluarga

    Riwayat penyakit serupa :

    disangkal

    Riwayat Hipertensi :disangkal

    Riwayat DM : disangkal

    Riwayat Jantung : disangkal

    6

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    7/29

    PEMERIKSAAN FISIK Keadaan Umum : sakit berat,

    compos mentis, gizi kurang

    Tanda Vital Tekanan darah : 60/40 mmHg

    Nadi : 124 x/menit

    Pernapasan : 40 x/menit Suhu : 38,7 C

    Saturasi O2 : 90 %

    7

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    8/29

    Kepala : normochepal, simetris. Mata : Conjungtiva anemis (-/-),

    sclera ikterik (-/-)

    Pupil isokor (3 mm/3mm),Reflek cahaya (+/+).

    Hidung : Nafas cuping hidung (+), darah (-),secret (-).

    Telinga : darah (-), secret (-).

    Mulut : mukosa basah (+), sianosis (-),

    lidah kotor (-). Leher : Simetris, limfonodi coli tidak

    membesar.

    Thorax : retraksi (+).

    8

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    9/29

    Jantung Inspeksi : ictus cordis tidak tampak

    Palpasi : ictus cordis tidak teraba

    Perkusi : batas jantung dalam batasnormal

    Auskultasi : BJ I-II intensitas normal, reguler,murmur (-), gallop (-)

    Paru

    Inspeksi : Saat statis bagian dada kanan samadengan bagian kiri, saat dinamis, gerakan

    dada kanan tertinggal dari kiri. Retraksiintercostal, dan subcostal ditemukan

    Palpasi : Fremitus taktil kanan lebih lemah dari kiri

    Perkusi : pekak/sonor

    Auskultasi : ronki +/-, wheezing -/-

    9

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    10/29

    Abdomen Inspeksi : tampak datar, dinding perut

    sejajar dengan dinding dada

    Auskultasi : bising usus (+)

    Perkusi : Tympani

    Palpasi : Supel, nyeri tekan (-),hepar/lien tidak teraba

    Trunk

    Inspeksi : Skoliosis (-), kifosis (-), lordosis (-)

    Palpasi : Nyeri tekan (-), massa (-) Perkusi : Nyeri ketok (-)

    Ekstremitas :Oedem -/- Akral dingin -/-

    10

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    11/29

    PEMERIKSAAN PENUNJANG Laboratorium (19 Januari 2013) :

    DL :

    Hb : 9,5 g/dL

    WBC : 34.600 /ul RBC : 4,46 juta /ul

    PLT : 437.000 /ul

    GDS : 94 mg/dL

    Ureum : 66,2 mg/dL

    Kreatinin : 2,02 mg/dL SGOT : 69,8 U/L

    SGPT : 33,4 U/L

    Albumin : 2,7 g/dL

    Globulin : 1,74 g/dL

    11

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    12/29

    UL : leukosit 10/ul, eritrosit 30/uL,epitel ++

    Feses lengkap :

    macros : konsistensi lembek,lendir, darah negatif

    micros : leukosit, eritrosit

    negatif BTA sputum S-P-S : negatif

    Kultur darah (22-1-2013) : hasil

    steril 12

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    13/29

    Foto Rontgen Thorax PA (23Januari 2013) :

    13

    Kesan:

    Efusi pleura

    dextra

    bronkopneumonia

    kardiomegalidengan elongatio

    aorta

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    14/29

    USG Abdomen (21 Januari 2013) :

    Complex pleural effusion supradiafragma dextra

    Pielonefritis sinistra

    Hepar,, lien, pancreas, vesica urinaria dalam batas normal

    Dilakukan pungsi pleura pada tanggal 19 januari 2013, kemudian dilakukan

    analisa dan sitologi cairan pleura, hasil :

    Analisa cairan pleura (21-1-2013) :

    Protein total serum : 5,76 g/dL, ratio 0,8 LDH serum : 291 U/L, ratio 3,2

    Glukosa : 72 mg/dL

    Pewarnaan BTA : negatif, pewarnaan gram : kokus gram positif

    Sifat cairan pleura adalah eksudat dengan infeksi sekunder oleh kuman

    kokus gram positif.

    Patologi anatomi cairan pleura (24-1-2013) :

    Sel malignancy negative

    Peradangan kronis supuratif (abses)

    14

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    15/29

    Diagnosa kerja:

    1.Pneumonia dengan efusi pleura dextra

    (parapneumonic syndrome)

    2.Diarrhea

    3. Malnutrisi underweight

    5. PENATALAKSANAAN

    O2 2L/mnt

    IVFD RL guyur 1 liter maintenance 40 tetes/menit

    Levofloxacin 1 x 750 mg i.v

    Ceftriaxone 2 x gr i.v Metronidazol 3 x 500 mg i.v

    Ranitidine 2 x 1 amp i.v

    Metoclopramid 2 x 1 amp i.v

    Diet : TKTP Nasi + ekstra telur

    6. PROGNOSIS

    Ad vitam : dubia

    Ad sanam : dubia

    Ad fungsionam : dubia

    15

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    16/29

    PARAPNEUMONIC

    SYNDROME

    (Parapneumonic effusions and empyema)

    16

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    17/29

    INTRODUCTION

    Parapneumonic syndrome : Pneumonia symptoms with parapneumonic

    effusion (exudative pleural effusion) that

    results from pneumonia (CAP/NP) or lung

    abses

    Between 20% and 57% of the 1 million

    patients hospitalized yearly in the U.S

    with pneumonia, develop a PPE. Empyema is less common, occurring

    in 5%10% of patients who experience

    PPE 17

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    18/29

    Figure 1. Causes of empyema in 14 prior studies. Of the 1383

    patients in the studies, 70% were parapneumonic. For the other

    30% of patients, trauma was the cause of empyema in 7%,

    empyema was postoperative in 6%, and prior tuberculosis was

    the cause in 4%; 12% of cases were due to other causes.

    18

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    19/29

    CLASSIFICATION

    Clinical classificationof PPE : 1. uncomplicated parapneumonic

    effusion (UPPE) 2. complicated parapneumonic effusion

    (CPPE) 3. Empyema

    Stages : 1. exudative 2. fibrinopurulent 3. final organizational

    19

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    20/29

    CLINICAL PRESENTATION

    Symptoms of pneumonia :

    Fever, malaise, cough, dyspnea,

    pleuritic chest pain

    Eldery patients >> asymptomatic

    20

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    21/29

    Pleural fluid analysis >>> to stage thePPE and guides initial management.

    UPPEs : have a turbid appearance, witha pH >7.30, a glucose level >60 mg/dL,

    an LDH level

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    22/29

    22

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    23/29

    recommended that all patients withpneumonia be evaluated for thepresence of pleural fluid.

    With the possible or definite presenceof pleural fluid noted on a chestradiograph, an ultrasound-guidedthoracentesis should be performed.

    Ultrasonography can detect strandingor septation in the fluid suggestive of aCPPE and can facilitate its drainage.

    23

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    24/29

    Figure 3.A complex, septate pleural effusion

    demonstrated by ultrasonography in a patient with

    spontaneous hemorrhage into a pre-existing pleural

    effusion. This precise pattern is typical of a complicatedparapneumoniceffusion as well. 24

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    25/29

    PATHOPHYSIOLOGY

    Figure 2. The estimated time course ofuntreated or inappropriately treatedparapneumonic effusions. In general,an empyema will develop 46 weeks

    after the onset of aspiration of bacteriainto the lung. 25

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    26/29

    MANAGEMENT

    In general, early and appropriateantibiotic treatment will prevent the

    development of a PPE and its

    progression.

    26

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    27/29

    MANAGEMENT Ant ib iot ic therapy: Early antibiotic therapy will prevent the development

    of a PPE and its progression to a CPPE and empyema.

    Pleural sp ace drainage :

    Clinical factors that suggestpleural space drainage include :

    prolonged pneumonia symptoms,

    Comorbid disease,

    failure to respond to antibiotic therapy, and presence of anaerobic organisms .

    Chest radiograph findings that suggest the need for pleural space

    drainage include an effusion involving >50% of the hemothorax

    Stranding or septation noted on an ultrasound suggests the need for

    pleural space drainage. Intrapleural f ibr inolyt ic s :fibrinolytic agents (urokinase and tissue

    plasminogen activator) most effective in the early fibrinolytic stage in

    avoiding the need for surgical drainage.

    Surgery :pleural space drainage by tube thoracostomy has been

    ineffective in controlling the pleural infection. (VATS).

    27

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    28/29

    CONCLUSIONS1. Early antibiotic treatment usually prevents the development of a PPE and its

    progression to a complicated PPE and empyema.

    2. Pleural fluid analysis provides diagnostic information and guides therapy.

    3. If the PPE is small to moderate in size, free-flowing, and nonpurulent (pH,

    >7.30), it is highly likely that antibiotic treatment alone will be effective.

    4. Prolonged pneumonia symptoms before evaluation, pleural fluid with a pH

  • 7/28/2019 PARAPNEUMONIC SYNDROME.pptx

    29/29

    TERIMA KASIH

    29